Captrust Financial Advisors Bicycle Therapeutics PLC Transaction History

Captrust Financial Advisors

  • $30 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$40.12 - $59.5 $76,468 - $113,407
-1,906 Reduced 84.34%
354 $16,000
Q3 2021

Nov 16, 2021
SELL
$27.95 - $44.24 $27,950 - $44,240
-1,000 Reduced 30.67%
2,260 $94,000
Q1 2021

May 17, 2021
BUY
$19.12 - $30.25 $4,971 - $7,865
260 Added 8.67%
3,260 $97,000
Q4 2020

Feb 16, 2021
BUY
$17.95 - $21.36 $53,850 - $64,080
3,000 New
3,000 $54,000

Others Institutions Holding BCYC

# of Institutions
99
Shares Held
30.6M
Call Options Held
85.5K
Put Options Held
11.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $600M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email